Key Insights

Highlights

Success Rate

70% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

27.3%

3 terminated out of 11 trials

Success Rate

70.0%

-16.5% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

70% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (5)
P 4 (2)

Trial Status

Completed7
Terminated3
Unknown1

Trial Success Rate

70.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (11)

Research Network

Activity Timeline